Early Vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Luisa Guidi 1
Daniela Pugliese 1
Tommaso Panici Tonucci 1
Lorenzo Bertani 2
Francesco Costa
Giuseppe Privitera
Elisa Gremese
Barbara Tolusso
Clara Di Mario
Alfredo Papa
Antonio Gasbarrini
Gian Lodovico Rapaccini
Alessandro Armuzzi
1 Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore,Roma,Italy
2 University of Pisa,Pisa,Italy
Session
IBD II (Posters)
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]